Diffusion Pharmaceuticals Inc (NASDAQ:DFFN)
| 0.8972 Delayed Data As of Mar 05 |  +0.001 / +0.11%Today’s Change | 0.25 Today|||52-Week Range 1.85 | +12.86% Year-to-Date |
Latest DFFN News | Press Releases
No recent news for Diffusion Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.90 |
| Today’s open | 1.05 |
| Day’s range | 0.78 - 0.93 |
| Volume | 94,732 |
| Average volume (3 months) | 5,495,249 |
| Market cap | $115.4M |
Data as of 7:13pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | +78.57% |
| Earnings growth (this year) | +85.23% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 89.7 |
| Price/Sales | -- |
| Price/Book | 1.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APMAptorum Group Ltd | +0.03 | +1.13% |
| SLSSellas Life Sciences... | -0.16 | -2.00% |
| CBLICleveland Biolabs In... | -0.11 | -1.87% |
| SVRASavara Inc | -0.12 | -6.98% |
Data as of 3:59pm ET, 03/05/2021
Financials
| Next reporting date | March 31, 2021 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$11.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Charlottesville, Virginia |
Forecasts
